The establishment of a WHO Reference Reagent for anti-malaria (Plasmodium falciparum) human serum by Silva, N, Rigsby, P, Dougall, T, Corran, P, Bowyer, PW, Ho, MM, Collaborative study group, Ndungu, F

Heterotypic interactions drive antibody synergy against a malaria vaccine candidate by Ragotte, RJ, Pulido, D, Lias, AM, Quinkert, D, Alanine, DGW, Jamwal, A, Davies, H, Nacer, A, Lowe, ED, Grime, GW, Illingworth, JJ, Donat, RF, Garman, EF, Bowyer, PW, Higgins, MK, Draper, SJ

Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies by Nacer, A, Kivi, G, Pert, R, Juronen, E, Holenya, P, Aliprandini, E, Amino, R, Silvie, O, Quinkert, D, Le Duff, Y, Hurley, M, Reimer, U, Tover, A, Draper, SJ, Gilbert, S, Ho, MM, Bowyer, PW